Your browser doesn't support javascript.
International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020.
Matheeussen, Veerle; Corman, Victor M; Donoso Mantke, Oliver; McCulloch, Elaine; Lammens, Christine; Goossens, Herman; Niemeyer, Daniela; Wallace, Paul S; Klapper, Paul; Niesters, Hubert Gm; Drosten, Christian; Ieven, Margareta.
  • Matheeussen V; Department of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
  • Corman VM; These authors contributed equally to this work and share first authorship.
  • Donoso Mantke O; National Consultant Laboratory for Coronaviruses, Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • McCulloch E; These authors contributed equally to this work and share first authorship.
  • Lammens C; Quality Control for Molecular Diagnostics (QCMD), Glasgow, United Kingdom.
  • Goossens H; These authors contributed equally to this work and share first authorship.
  • Niemeyer D; Quality Control for Molecular Diagnostics (QCMD), Glasgow, United Kingdom.
  • Wallace PS; Department of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
  • Klapper P; Department of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
  • Niesters HG; National Consultant Laboratory for Coronaviruses, Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Drosten C; Quality Control for Molecular Diagnostics (QCMD), Glasgow, United Kingdom.
  • Ieven M; School of Biological Sciences, Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom.
Euro Surveill ; 25(27)2020 07.
Artículo en Inglés | MEDLINE | ID: covidwho-845124
ABSTRACT
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Coronavirus / Técnicas de Laboratorio Clínico / Técnicas de Diagnóstico Molecular / Pandemias Tipo de estudio: Estudios diagnósticos / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: Europa Idioma: Inglés Asunto de la revista: Enfermedades Transmisibles Año: 2020 Tipo del documento: Artículo País de afiliación: 1560-7917.ES.2020.25.27.2001223

Similares

MEDLINE
LILACS
LIS
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Coronavirus / Técnicas de Laboratorio Clínico / Técnicas de Diagnóstico Molecular / Pandemias Tipo de estudio: Estudios diagnósticos / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: Europa Idioma: Inglés Asunto de la revista: Enfermedades Transmisibles Año: 2020 Tipo del documento: Artículo País de afiliación: 1560-7917.ES.2020.25.27.2001223